Expert Opinion on Drug Metabolism and Toxicology,volume 9,issue 6  (06-2014)

Period of time： 2014年6期

Publisher： Informa Healthcare

Founded in： 2005

Total resources： 64

ISSN： 1742-5255

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Expert Opinion on Drug Metabolism and Toxicology,volume 9,issue 6

Menu

Metabolic and toxicological considerations for obsessive-compulsive disorder drug therapy

By Sayyah Mohammad in (2013)

Expert Opinion on Drug Metabolism and Toxicology,volume 9,issue 6 , Vol. 9, Iss. 6, 2013-06 , pp. 657-673

Informa Healthcare

Abstract Access to resources Recommend Favorite

Metabolic and toxicological considerations of the opioid replacement therapy and analgesic drugs: methadone and buprenorphine

By Moody David E in (2013)

Expert Opinion on Drug Metabolism and Toxicology,volume 9,issue 6 , Vol. 9, Iss. 6, 2013-06 , pp. 675-697

Informa Healthcare

Abstract Access to resources Recommend Favorite

Alternative methods for ocular toxicology testing: validation, applications and troubleshooting

By Dholakiya Sanjay L in (2013)

Expert Opinion on Drug Metabolism and Toxicology,volume 9,issue 6 , Vol. 9, Iss. 6, 2013-06 , pp. 699-712

Informa Healthcare

Abstract Access to resources Recommend Favorite

Role of microRNAs in the regulation of drug metabolism and disposition genes in diabetes and liver disease

By Pogribny Igor P,Beland Frederick A in (2013)

Expert Opinion on Drug Metabolism and Toxicology,volume 9,issue 6 , Vol. 9, Iss. 6, 2013-06 , pp. 713-724

Informa Healthcare

Abstract Access to resources Recommend Favorite

Utilization of glutathione S-transferase Mu 1 - and Theta 1 -null mice as animal models for absorption, distribution, metabolism, excretion and toxicity studies

By Arakawa Shingo in (2013)

Expert Opinion on Drug Metabolism and Toxicology,volume 9,issue 6 , Vol. 9, Iss. 6, 2013-06 , pp. 725-736

Informa Healthcare

Abstract Access to resources Recommend Favorite

Optimizing the in vitro and clinical assessment of drug interaction risk by understanding co-medications in patient populations

By Bloomer Jackie in (2013)

Expert Opinion on Drug Metabolism and Toxicology,volume 9,issue 6 , Vol. 9, Iss. 6, 2013-06 , pp. 737-751

Informa Healthcare

Abstract Access to resources Recommend Favorite

A pharmacokinetic and clinical assessment of tofacitinib for the treatment of rheumatoid arthritis

By Bannwarth Bernard,Kostine Marie,Poursac Nicolas in (2013)

Expert Opinion on Drug Metabolism and Toxicology,volume 9,issue 6 , Vol. 9, Iss. 6, 2013-06 , pp. 753-761

Informa Healthcare

Abstract Access to resources Recommend Favorite

Canagliflozin, an inhibitor of sodium-glucose cotransporter 2, for the treatment of type 2 diabetes mellitus

By Lamos Elizabeth M in (2013)

Expert Opinion on Drug Metabolism and Toxicology,volume 9,issue 6 , Vol. 9, Iss. 6, 2013-06 , pp. 763-775

Informa Healthcare

Abstract Access to resources Recommend Favorite

Pharmacokinetics and pharmacodynamics of sunitinib for the treatment of advanced pancreatic neuroendocrine tumors

By Bisht Savita,Feldmann Georg,Brossart Peter in (2013)

Expert Opinion on Drug Metabolism and Toxicology,volume 9,issue 6 , Vol. 9, Iss. 6, 2013-06 , pp. 777-788

Informa Healthcare

Abstract Access to resources Recommend Favorite

Pharmacokinetic and pharmacodynamics evaluation of ceftobiprole medocaril for the treatment of hospital-acquired pneumonia

By Lagacé-Wiens Philippe RS in (2013)

Expert Opinion on Drug Metabolism and Toxicology,volume 9,issue 6 , Vol. 9, Iss. 6, 2013-06 , pp. 789-799

Informa Healthcare

Abstract Access to resources Recommend Favorite

Total 10 item(s)